Cancer Cause and Prevention Research in South Carolina
Cancer Cause and Prevention Research (93.393) awarded $54.8 million to recipients in South Carolina in 39 grants from fiscal 2021 to 2025, 1.5% of the program's national total. The Medical University of South Carolina received the most, $43.7 million.
- Awarded in South Carolina$54.8 million
- Awards39
- Share of the program1.5%
- Rank among states19th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 15 | $8.2 million |
| FY 2022 | 20 | $10.8 million |
| FY 2023 | 19 | $12.3 million |
| FY 2024 | 23 | $9.9 million |
| FY 2025 | 22 | $13.6 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Medical University of South Carolina | Colleges and universities | 27 | $43.7 million |
| University of South Carolina | Colleges and universities | 9 | $10.2 million |
| Pranascience Institute LLC | Small businesses | 1 | $510,312 |
| Leukogene Therapeutics Inc | Small businesses | 2 | $400,000 |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 60 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to South Carolina?
$54.8 million from fiscal 2021 to 2025, across 39 awards. South Carolina ranks 19th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in South Carolina?
The largest recipient is The Medical University of South Carolina, with $43.7 million in 27 awards. Next are University of South Carolina and Pranascience Institute LLC.
Can organizations in South Carolina apply now?
Yes, 60 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start